WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 591218
Description: 7-Deoxyadriamycinol aglycone is an adriamycin metabolite.
MedKoo Cat#: 591218
Name: 7-Deoxyadriamycinol aglycone
Chemical Formula: C21H20O8
Exact Mass: 400.1158
Molecular Weight: 400.38
Elemental Analysis: C, 63.00; H, 5.04; O, 31.97
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: 7-Deoxyadriamycinol aglycone;
IUPAC/Chemical Name: 5,12-Naphthacenedione, 8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (S-(R*,S*))-
InChi Key: IGJIPNOEJDYNRR-ASSNKEHSSA-N
InChi Code: InChI=1S/C21H20O8/c1-29-12-4-2-3-10-14(12)20(27)16-15(18(10)25)19(26)11-7-21(28,13(23)8-22)6-5-9(11)17(16)24/h2-4,13,22-24,26,28H,5-8H2,1H3/t13-,21+/m1/s1
SMILES Code: O=C(C1=C2C(O)=C3CC[C@@](O)([C@H](O)CO)CC3=C1O)C4=CC=CC(OC)=C4C2=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 400.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Gille L, Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med. 1997;23(5):775-82. PubMed PMID: 9296455.
2: Samuel L. Doxorubicin-induced cardiotoxicity. Postgrad Med J. 1995 May;71(835):318. PubMed PMID: 7596949; PubMed Central PMCID: PMC2398096.
3: Cummings J, Milstead R, Cunningham D, Kaye S. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum. Eur J Cancer Clin Oncol. 1986 Aug;22(8):991-1001. PubMed PMID: 3770056.
4: Dodion P, Riggs CE Jr, Akman SR, Bachur NR. Effect of hyperthermia on the in vitro metabolism of doxorubicin. Cancer Treat Rep. 1986 May;70(5):625-9. PubMed PMID: 3708610.
5: Creagan ET, Ahmann DL, Frytak S, Long HJ, Chang MN, Itri LM. Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients. Cancer Treat Rep. 1986 May;70(5):619-24. PubMed PMID: 3518925.
6: Vrignaud P, Londos-Gagliardi D, Robert J. Hepatic metabolism of doxorubicin in mice and rats. Eur J Drug Metab Pharmacokinet. 1986 Apr-Jun;11(2):101-5. PubMed PMID: 3770010.
7: Cummings J, Merry S, Willmott N. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS). Eur J Cancer Clin Oncol. 1986 Apr;22(4):451-60. PubMed PMID: 3460809.
8: Dodion P, Riggs CE Jr, Akman SR, Tamburini JM, Colvin OM, Bachur NR. Interactions between cyclophosphamide and adriamycin metabolism in rats. J Pharmacol Exp Ther. 1984 Apr;229(1):51-7. PubMed PMID: 6423814.
9: Marshall VP, McGovren JP, Richard FA, Richard RE, Wiley PF. Microbial metabolism of anthracycline antibiotics daunomycin and adriamycin. J Antibiot (Tokyo). 1978 Apr;31(4):336-42. PubMed PMID: 26650.